Nanox reported second quarter 2026 revenue of $4.2 million, a 37% increase year-over-year but missing the consensus estimate of $5.38 million. The company's GAAP net loss widened significantly to $55.5 million, primarily driven by a $40.7 million non-cash impairment charge on intangible assets within its AI solutions unit. Liquidity remains a critical concern as cash and equivalents fell to $31.4 million from $60.0 million at the end of 2025, although the company raised an additional $8.5 million post-quarter to bolster its balance sheet.
Key Highlights
- A $40.7 million impairment charge was recognized due to a decline in share price and reduced financial forecasts for the AI business unit.
- Restructuring of South Korea operations included a 67% workforce reduction, intended to generate $2 million in annual savings starting in 2027.
- AI and software solutions revenue reached $1.0 million, meeting expectations following the full integration of Nanox Health IT.
- Teleradiology services contributed $3.0 million to total revenue, while the first Nanox Imaging Network site in Philadelphia began receiving insurance scan reimbursements.